Feasibility and Efficacy of Local Radiotherapy With Concurrent Novel Agents in Patients With Multiple Myeloma.

CONCLUSION: Treating MM with RT concurrently with CTx including NAs was safe and well tolerated in the majority of patients (14 of 16 [87.5%] for those taking NAs and 19 of 21 [90.5%] for all patients). Excellent clinical pain response (> 95%) was also seen in patients regardless if they were treated with RT + ST or RT alone.
PMID: 25176474 [PubMed - as supplied by publisher]

Source: Clinical Lymphoma and Myeloma - August 1, 2014 Category: Cancer & Oncology Authors: Shin SM, Chouake RJ, Sanfilippo NJ, Rapp TB, Cook P, Formenti SC, Mazumder A, Silverman JS Tags: Clin Lymphoma Myeloma Leuk Source Type: research